© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 05, 2021
Risk factors for norovirus include eating foods in non-sanitary places and attending childcare centers or preschools.
February 25, 2021
The approval makes adalimumab the only subcutaneous biologic for pediatric patients with ulcerative colitis that can be administered at home.
February 16, 2021
Data from the FIGHT trial suggests that approximately 30% of patients with non-human epidermal growth factor 2-positive GEJ cancers overexpress fibroblast growth factor receptor 2.
February 11, 2021
The efficacy results demonstrated that there were 4 patients with confirmed partial response, and an additional 3 patients had stable disease lasting 16 weeks or longer.
January 11, 2021
A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.
November 11, 2020
Despite presenting in only 18% of cases, 16% of all COVID-19 patients only present with gastrointestinal symptoms.
November 04, 2020
The FDA granted breakthrough therapy designation to dupilumab in September 2020, for the treatment of patients age 12 years and older with eosinophilic esophagitis.
October 16, 2020
Educate patients about the appropriate and safe use of gastrointestinal products and direct them to seek further medical care when warranted.
October 06, 2020
Like diabetes, Inflammatory bowel disease may also be linked to a high-fructose diet.
October 01, 2020
Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.